ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

263
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
12 Aug 2021 09:23

Pre-IPO Ambio Pharmaceuticals - The Particularity of Peptide Drugs, the Strength and the Concerns

The article mainly analyzed Ambio Pharmaceuticals in terms of the particularity of peptide drugs & industry characteristics, the strength of its...

Logo
526 Views
Share
11 Aug 2021 09:00

Pre-IPO Asymchem Laboratories - The Strength and the Concerns

The article mainly analyzed Asymchem Laboratories in terms of the industry characteristics, the strength of its business, the comparison with...

Logo
275 Views
Share
04 Aug 2021 09:18

Pre-IPO Sinohealth Technology - Solid Financial Performance Cannot Cover up the Challenges Ahead

This article mainly analyzed Sinohealth in terms of the industry characteristics, its business, comparison with peers (Yidu Tech, Linkdoc, etc.),...

Logo
293 Views
Share
30 Jul 2021 09:33

China A-Shares - EM Fund Ownership Guide

China A-Shares represent the 6th largest country holding among active EM investors.  In this analysis, we analyse the current set up of A-Shares in...

Logo
261 Views
Share
27 Jul 2021 10:03

Asymchem Labs A/H Listing Early Look - Fast Growing, Relatively Insulated

Asymchem Laboratories (002821 CH) (AL) aims to raise around US$1-1.5bn in its H-share listing in Hong Kong. The A-shares listed were listed in...

Logo
218 Views
Share
x